Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in Melanoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in Melanoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-14
DOI
10.3389/fonc.2020.00758
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer
- (2019) Triparna Sen et al. Cancer Discovery
- Pharmacological Modulation of the STING Pathway for Cancer Immunotherapy
- (2019) Gilles Berger et al. TRENDS IN MOLECULAR MEDICINE
- cGAS in action: Expanding roles in immunity and inflammation
- (2019) Andrea Ablasser et al. SCIENCE
- Autophagy induction via STING trafficking is a primordial function of the cGAS pathway
- (2019) Xiang Gui et al. NATURE
- Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
- (2019) Anping Li et al. Journal of Hematology & Oncology
- MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models
- (2018) Zheng Xue et al. CELL RESEARCH
- Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors
- (2018) Raeeka Khamari et al. Cell Death & Disease
- Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids
- (2018) Xiaojun Tan et al. Annual Review of Microbiology
- Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming
- (2018) David Olagnier et al. Nature Communications
- Design of amidobenzimidazole STING receptor agonists with systemic activity
- (2018) Joshi M. Ramanjulu et al. NATURE
- Type I interferon enhances necroptosis ofSalmonellaTyphimurium–infected macrophages by impairing antioxidative stress responses
- (2017) Nina Judith Hos et al. JOURNAL OF CELL BIOLOGY
- ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
- (2017) Giulia Cesi et al. Molecular Cancer
- Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis
- (2016) Tianli Xia et al. CANCER RESEARCH
- Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
- (2016) Qi Chen et al. NATURE IMMUNOLOGY
- Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction
- (2015) Gatien Moriceau et al. CANCER CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
- (2015) S. Liu et al. SCIENCE
- Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma
- (2015) Neel M. Fofaria et al. Oncotarget
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling
- (2014) Xin Cai et al. MOLECULAR CELL
- The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury
- (2014) J-X Li et al. Cell Death & Disease
- A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
- (2014) D. J. Konieczkowski et al. Cancer Discovery
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012
- (2012) Claus Garbe et al. EUROPEAN JOURNAL OF CANCER
- The role of BRAF V600 mutation in melanoma
- (2012) Paolo A Ascierto et al. Journal of Translational Medicine
- Dabrafenib and its potential for the treatment of metastatic melanoma
- (2012) Rajmohan Murali et al. Drug Design Development and Therapy
- Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
- (2011) P. A. Konstantinopoulos et al. CANCER RESEARCH
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- (2009) Hiroki Ishikawa et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started